Appoints Michael Krall as President and COO.
Newport Beach, CA March 18, 2020 BioQuest Corp, (OTC:BQST), a provider of high end CBD products to the retail, direct and internet markets, announced it has appointed Michael Krall as President, COO and a member of the BOD.
BioQuest, Corporation - markets, packages and distributes an assortment of Hemp-CBD based products for the health-conscious consumer. Our mission is to create high end, products and bring together all relevant CBD content in the Nutraceutical and Pharmaceutical markets, to one place so that it is easily found and comparable by consumers. BioQuest will also be positioned to generate revenue by acquiring established companies who have a current presence in the nutraceutical cannabis industry as well as by bringing new products to market that will generate immediate revenues and will be created and marketed by BioQuest.
Michael Krall President and COO, said, we are building one of the strongest and most recognizable brands in the Hemp / CBD Nutraceutical industry. We will be releasing a variety of products including food, dietary supplements, cosmetics, and animal health products over the next two years. BioQuest believes that CBD will be most effective with a total Lifestyle change, implementing small dosages via multiple products, throughout the day. We recognized early adoption of CBD will create large opportunities for BioQuest. Our newest product branded with CBD3tm will inherit the Quality Integrity Lifestyle, reputation.
Since the partial legalization of medical and recreational CBD, numerous states have created new and exciting markets with great marketing and sales potential. Once federal laws allow wider use of cannabis the cannabis space is going to be a sunrise industry with huge growth potentials; in all areas of ones life from medical uses, pharmaceutical, nutraceutical, pets and recreational.
About Mr. Krall
Michael Krall: President, COO and Board Member of BioQuest Corporation, since October 2019 to current. Mr. Krall was the founder of PURE Bioscience, Inc.(OTC:PURE) Where he has held the positions of President, CEO and Chairman of the Board from 1998 to 2014. From 2015 to present, Mr. Krall has advised companies on biotech products and processes. Additionally, he is an inventor and co-inventor of dozens of domestic and international patented biotech products. Mr. Krall brings a wealth of knowledge of the biotech, manufacturing and securities industries including leadership ability, dedication and commitment to excellence make him well suited to this highly regulated industry.
About BioQuest Corp.
BioQuest Corp. sells primarily into the business-to-business market and internet-based consumer to consumer, which includes legally operating medical and adult-use dispensaries, growers, and brand owners in states with cannabis and CBD programs. We plan to reach a large and diversified customer base through our direct sales force, our user-friendly website, and the strategic use of re-distributors. Sales, fulfillment and support staff meet with customers to understand their needs and improve our product offerings and services. We will dedicate certain sales and marketing efforts to our products, customers or geographic regions, as necessary, which enables us to develop expertise that is highly valued by our customers. BioQuest is Headquartered in Newport Beach, CA. Additional information on BQST is available at www.bioquestcorp.com
Forward-looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Statements in this press release concerning the company's expectations, plans, business outlook or future performance, and any other statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are forward-looking statements. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from any forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company's failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans; acceptance of the Company's current and future products and services in the marketplace, including the Company's ability to convert successful evaluations and tests BioQuest CBD products into customer orders and customers continuing to place product orders as expected and to expand their use of the Company's products; the Company's ability to raise the funding required to support its continued operations and the implementation of its business plan; the ability of the Company to develop effective new products and receive required approvals; competitive factors, including customer acceptance of the Company's CBD-based products that are typically more expensive than existing Products; dependence upon third-party vendors, including to manufacture its products; and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission (the SEC), including its Form 10-K and 10-Qs.
AI
